Anzeige von nach Autor Cacabelos, R.

Gehe zu: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
oder geben Sie die Anfangszeichen ein:  
Anzeige der Treffer 1 bis 9 von 9
VorschauErscheinungsdatumTitelAutor(en)
2018Basic and Clinical Studies With Marine LipoFishins and Vegetal Favalins in Neurodegeneration and Age-Related DisordersCacabelos, R.; Lombardi, V.; Carrera, I.; Cacabelos, P.; Corzo, L.; Carril, J.C.; Teijido, O.; Fernández-Novoa, L.
2017Biochemistry, cytogenetics and DMD gene mutations in South Indian patients with duchenne muscular dystrophyMeyyazhagan, A.; Raman, N. M.; Easwaran, M; Balasubramanian, B; Alagamuthu, K.; Bhotla, H. Kuchi; Shanmugam, S.; Inbaraj, K.; Kumar, M. Ramesh; Kumar, P.; Thangamani, L.; Piramanayagam, S.; Anand, V.; Mohd, Y.; Park, S.; Teijido, O.; Carril, J. C.; Cacabelos, P.; Keshavarao, S.; Cacabelos, R.
1-Jan-2018Epigenetics of brain agingCacabelos, R.; Teijido, O.
2018Have there been improvements in Alzheimer’s disease drug discovery over the past 5 years?Cacabelos, R.
2018Pharmacoepigenomic interventions as novel potential treatments for Alzheimer’s and Parkinson’s diseasesTeijido, O.; Cacabelos, R.
2018Pharmacogenetics of vascular risk factors in Alzheimer’s diseaseCacabelos, R.; Meyyazhagan, A.; Carril, J.C.; Cacabelos, P.; Teijido, Ó.
1-Mai-2020Pharmacogenomics of Alzheimer's and Parkinson's diseasesCacabelos, R.
2018Pleiotropy and promiscuity in pharmacogenomics for the treatment of Alzheimer's disease and related risk factorsCacabelos, R.
2018Population-level pharmacogenomics for precision drug development in dementiaCacabelos, R.